Literature DB >> 21276007

Role of TLR2-dependent inflammation in metastatic progression.

Sunhwa Kim1, Michael Karin.   

Abstract

Inflammation is a part of the host defense system, which provides protection against invading pathogens. However, it has become increasingly clear that inflammation can be evoked by endogenous mediators through Toll-like receptors (TLRs) to enhance tumor progression and metastasis. Here, we discuss the roles of TLR-mediated inflammation in tumor progression and the mechanisms through which it accomplishes this pathogenic function.
© 2011 New York Academy of Sciences.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21276007      PMCID: PMC4383094          DOI: 10.1111/j.1749-6632.2010.05882.x

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN: 0077-8923            Impact factor:   5.691


  172 in total

Review 1.  Age-associated increased interleukin-6 gene expression, late-life diseases, and frailty.

Authors:  W B Ershler; E T Keller
Journal:  Annu Rev Med       Date:  2000       Impact factor: 13.739

2.  Two distinct cytokines released from a human aminoacyl-tRNA synthetase.

Authors:  K Wakasugi; P Schimmel
Journal:  Science       Date:  1999-04-02       Impact factor: 47.728

Review 3.  An overview of epithelio-mesenchymal transformation.

Authors:  E D Hay
Journal:  Acta Anat (Basel)       Date:  1995

4.  Cutting edge: heat shock protein 60 is a putative endogenous ligand of the toll-like receptor-4 complex.

Authors:  K Ohashi; V Burkart; S Flohé; H Kolb
Journal:  J Immunol       Date:  2000-01-15       Impact factor: 5.422

5.  Fibrinogen stimulates macrophage chemokine secretion through toll-like receptor 4.

Authors:  S T Smiley; J A King; W W Hancock
Journal:  J Immunol       Date:  2001-09-01       Impact factor: 5.422

6.  Novel signal transduction pathway utilized by extracellular HSP70: role of toll-like receptor (TLR) 2 and TLR4.

Authors:  Alexzander Asea; Michael Rehli; Edith Kabingu; Jason A Boch; Olivia Bare; Philip E Auron; Mary Ann Stevenson; Stuart K Calderwood
Journal:  J Biol Chem       Date:  2002-02-08       Impact factor: 5.157

7.  Maspin, a serpin with tumor-suppressing activity in human mammary epithelial cells.

Authors:  Z Zou; A Anisowicz; M J Hendrix; A Thor; M Neveu; S Sheng; K Rafidi; E Seftor; R Sager
Journal:  Science       Date:  1994-01-28       Impact factor: 47.728

8.  Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) is an inhibitor of autoimmune inflammation and cell cycle progression.

Authors:  K Song; Y Chen; R Göke; A Wilmen; C Seidel; A Göke; B Hilliard; Y Chen
Journal:  J Exp Med       Date:  2000-04-03       Impact factor: 14.307

9.  Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) contributes to interferon gamma-dependent natural killer cell protection from tumor metastasis.

Authors:  M J Smyth; E Cretney; K Takeda; R H Wiltrout; L M Sedger; N Kayagaki; H Yagita; K Okumura
Journal:  J Exp Med       Date:  2001-03-19       Impact factor: 14.307

10.  Cachectin/tumor necrosis factor mediates changes of skeletal muscle plasma membrane potential.

Authors:  K J Tracey; S F Lowry; B Beutler; A Cerami; J D Albert; G T Shires
Journal:  J Exp Med       Date:  1986-10-01       Impact factor: 14.307

View more
  32 in total

1.  Toll-like receptor 2 mediates microglia/brain macrophage MT1-MMP expression and glioma expansion.

Authors:  Katyayni Vinnakota; Feng Hu; Min-Chi Ku; Petya B Georgieva; Frank Szulzewsky; Andreas Pohlmann; Sonia Waiczies; Helmar Waiczies; Thoralf Niendorf; Seija Lehnardt; Uwe-Karsten Hanisch; Michael Synowitz; Darko Markovic; Susanne A Wolf; Rainer Glass; Helmut Kettenmann
Journal:  Neuro Oncol       Date:  2013-09-05       Impact factor: 12.300

Review 2.  Animal models and the tumor microenvironment: studies of tumor-host symbiosis.

Authors:  Daniel Lindner
Journal:  Semin Oncol       Date:  2014-02-14       Impact factor: 4.929

3.  Role for B-cell adapter for PI3K (BCAP) as a signaling adapter linking Toll-like receptors (TLRs) to serine/threonine kinases PI3K/Akt.

Authors:  Ty Dale Troutman; Wei Hu; Stephanie Fulenchek; Tetsuo Yamazaki; Tomohiro Kurosaki; J Fernando Bazan; Chandrashekhar Pasare
Journal:  Proc Natl Acad Sci U S A       Date:  2011-12-20       Impact factor: 11.205

Review 4.  A role for proteoglycans in vascular disease.

Authors:  Thomas N Wight
Journal:  Matrix Biol       Date:  2018-02-27       Impact factor: 11.583

5.  Myeloid-derived suppressor cells and myeloid regulatory cells in cancer and autoimmune disorders.

Authors:  Prince Amoah Barnie; Pan Zhang; Hongxiang Lv; Dan Wang; Xiaolian Su; Zhaoliang Su; Huaxi Xu
Journal:  Exp Ther Med       Date:  2016-12-30       Impact factor: 2.447

Review 6.  Extracellular matrix and the myeloid-in-myeloma compartment: balancing tolerogenic and immunogenic inflammation in the myeloma niche.

Authors:  Fotis Asimakopoulos; Chelsea Hope; Michael G Johnson; Adam Pagenkopf; Kimberly Gromek; Bradley Nagel
Journal:  J Leukoc Biol       Date:  2017-03-02       Impact factor: 4.962

7.  TLR2 enhances ovarian cancer stem cell self-renewal and promotes tumor repair and recurrence.

Authors:  Ilana Chefetz; Ayesha B Alvero; Jennie C Holmberg; Noah Lebowitz; Vinicius Craveiro; Yang Yang-Hartwich; Gang Yin; Lisa Squillace; Marta Gurrea Soteras; Paulomi Aldo; Gil Mor
Journal:  Cell Cycle       Date:  2013-01-16       Impact factor: 4.534

8.  Distinct signaling pathways regulate TLR2 co-stimulatory function in human T cells.

Authors:  Nicole M Chapman; Mahmood Y Bilal; Noemi Cruz-Orcutt; Cory Knudson; Sofia Madinaveitia; Jonathan Light; Jon C D Houtman
Journal:  Cell Signal       Date:  2012-12-05       Impact factor: 4.315

Review 9.  microRNAs and Corresponding Targets Involved in Metastasis of Colorectal Cancer in Preclinical In Vivo Models.

Authors:  Ulrich H Weidle; Ulrich Brinkmann; Simon Auslaender
Journal:  Cancer Genomics Proteomics       Date:  2020 Sep-Oct       Impact factor: 4.069

10.  The cardioprotective protein apolipoprotein A1 promotes potent anti-tumorigenic effects.

Authors:  Maryam Zamanian-Daryoush; Daniel Lindner; Thomas C Tallant; Zeneng Wang; Jennifer Buffa; Elizabeth Klipfell; Yvonne Parker; Denise Hatala; Patricia Parsons-Wingerter; Pat Rayman; Mohamed Sharif S Yusufishaq; Edward A Fisher; Jonathan D Smith; Jim Finke; Joseph A DiDonato; Stanley L Hazen
Journal:  J Biol Chem       Date:  2013-05-17       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.